Related by context. All words. (Click for frequent words.) 68 cardioprotective effects 67 β blockers 66 cardio protective 66 antioxidant supplementation 65 CYP #A# 65 thiazide 65 pharmacokinetic interactions 65 adrenal suppression 64 antiphospholipid antibodies 64 coadministration 64 paricalcitol 63 pleiotropic effects 63 fluvastatin 63 renal toxicity 63 CYP#D# inhibitors 63 hepatotoxicity 63 cardioprotection 63 clomipramine 63 selective modulator 63 eosinophil count 63 chemopreventive agent 62 serum retinol 62 ABCB1 62 flecainide 62 triglyceride lowering 62 plasma lipid 62 HMG CoA reductase inhibitors 62 erythropoietic 62 antiplatelet drugs 62 probiotic supplementation 62 angiotensin II receptor blockers 62 Spironolactone 62 metabolic parameters 62 selenium supplementation 62 pentoxifylline 61 CYP#D# inhibitor 61 macrovascular disease 61 L lysine 61 proinflammatory cytokine 61 vasomotor symptoms 61 analgesic effects 61 antiandrogens 61 beta carotene supplementation 61 gastrointestinal absorption 61 torsade de pointes 61 ATACAND 61 QT prolongation 61 immunomodulatory effects 61 sulphonylureas 61 ovarian hormones 61 mycophenolate mofetil 61 lipid parameters 61 lipid lowering therapies 61 Torsades de Pointes 61 myopathy rhabdomyolysis 61 chlorthalidone 60 antitumor efficacy 60 vasodilatation 60 QTc prolongation 60 hyperinsulinemia 60 pharmacokinetic interaction 60 antitumor effects 60 nephrotoxicity 60 thrombotic events 60 K ras mutations 60 Topiramate 60 haloperidol Haldol 60 XZK 60 hemodilution 60 hyperglycaemia 60 lupus anticoagulant 60 cardiovascular morbidity 60 antidiabetic medications 60 ursodeoxycholic acid 60 hepatic toxicity 60 adiponectin levels 60 antiarrhythmic drugs 60 biologic plausibility 60 predisposing factor 60 colorectal adenoma 60 Calcium intake 60 cyclo oxygenase 60 hydroxychloroquine 60 plasma pharmacokinetics 60 GLP 1R 60 Hypoglycaemia 60 NNRTI resistance 60 antiarrhythmic 60 ranolazine 60 Subgroup analyzes 60 Carvedilol 60 myocardial fibrosis 60 tHcy 60 biochemical abnormalities 60 antidepressant efficacy 60 atorvastatin Lipitor 60 thiopurine 60 TZDs 60 AST ALT 60 endometrial hyperplasia 60 cardiac toxicity 60 genetic polymorphisms 60 hyperalgesia 60 insulin sensitizing 60 QTc intervals 60 platelet activation 60 venlafaxine Effexor 60 leukotriene receptor antagonists 60 dexrazoxane 60 immunomodulation 59 estrogen metabolism 59 olmesartan 59 inhibiting COX 59 TT genotype 59 inhibitory effect 59 quetiapine Seroquel 59 sotalol 59 plasma lipids 59 Venlafaxine 59 receptor inhibitor 59 Hypotension 59 improves insulin sensitivity 59 thromboembolic complications 59 endocannabinoid signaling 59 thromboembolism 59 cardiac valvulopathy 59 chromium supplementation 59 anti androgen 59 potentially modifiable 59 primary aldosteronism 59 Angiotensin converting enzyme 59 agonist induced 59 conjugated estrogen 59 biological plausibility 59 angiographically 59 triacylglycerol concentrations 59 Erythropoietic therapies may 59 amifostine 59 statin medications 59 danazol 59 platelet inhibition 59 ALB # 59 mitochondrial toxicity 59 vasoconstrictor 59 aldosterone antagonists 59 vasodilators 59 immunomodulatory agents 59 zoledronate 59 glitazones 59 prognostic significance 59 lipid abnormalities 59 Subgroup analysis 59 receptor blocker 59 corticosteroid therapy 59 statins cholesterol lowering 59 prostate carcinogenesis 59 hypercoagulable 59 norethindrone acetate 59 hepatotoxic 59 adrenal function 59 riociguat 59 NMDA receptor antagonists 59 atherogenesis 59 recurrent venous thromboembolism 59 thromboembolic disease 59 lipid profiles 59 creatine supplementation 59 NPH insulin 59 metabolic disturbances 59 inflammatory biomarkers 59 pyridostigmine 59 isoproterenol 59 Effexor venlafaxine 59 paroxetine sertraline 59 deferiprone 59 ventricular tachyarrhythmia 58 neurodevelopmental outcome 58 5 HT1A 58 CYP#D# 58 gene polymorphism 58 Hepatotoxicity 58 DHEA supplementation 58 MULTAQ 58 aminophylline 58 residual confounding 58 aspirin clopidogrel 58 serum homocysteine 58 fulvestrant 58 Avandia Actos 58 p# activation 58 impair fertility 58 antitumor effect 58 relieving menopausal symptoms 58 lipid concentrations 58 benfotiamine 58 medroxyprogesterone 58 venlafaxine 58 anticancer activity 58 loop diuretics 58 acitretin 58 QT interval prolongation 58 thromboembolic events 58 inverse association 58 thyrotropin 58 endogenous estrogen 58 perioperatively 58 tumor necrosis 58 serum leptin 58 atherogenic 58 eplerenone 58 intensive statin therapy 58 postmenopausal estrogen 58 PPARγ 58 calcium antagonists 58 periprocedural MI 58 rosuvastatin Crestor 58 carotid IMT 58 Tasigna prolongs 58 hematological parameters 58 dose proportionality 58 MTHFR 58 G6PD deficiency 58 metabolic acidosis 58 resolvin E1 58 oxcarbazepine 58 serum BDNF 58 thromboembolic 58 exocrine pancreas 58 elevated triglyceride levels 58 underlying pathophysiology 58 anticoagulant warfarin 58 PDE4 inhibitors 58 fibrate drugs 58 COX inhibitors 58 risedronate Actonel 58 thiazolidinediones 58 receptor subtypes 58 familial predisposition 58 oxysterols 58 glucose lowering 58 neuroprotective effects 58 neuropsychiatric symptoms 58 vasodilatory 58 androgen suppression 58 carotid plaque 58 pharmacologic intervention 58 EDARBI 58 ACEIs 58 Ascherio 58 antiresorptive 58 antiplatelet medications 58 pressor response 58 cardiac repolarization 58 antiplatelet therapies 58 N acetylcysteine 58 extrapyramidal symptoms 58 androgen deprivation 58 losartan Cozaar 58 LDL cholesterol lowering 58 abnormal lipids 58 ß blockers 58 APOE genotype 58 AVANDIA 58 postoperative AF 58 hypercalcemia 58 parecoxib 58 glycated hemoglobin levels 58 postmenopausal hormones 58 nicotinic acid 58 CYP#D# genotype 58 pressure natriuresis 58 tranylcypromine 58 induced oxidative stress 58 aminotransferases 58 Vitamin K2 58 arterial calcification 58 inhibitory effects 58 familial clustering 58 monoamine oxidase inhibitors 58 PTPN# 58 testosterone supplementation 58 antidiabetic drugs 58 angiotensin receptor blockers 58 microvascular disease 57 physiologic mechanisms 57 hepatic fibrosis 57 prostate cancer CaP 57 subclinical hypothyroidism 57 serum urate levels 57 cerivastatin 57 systemic toxicity 57 tibolone 57 omeprazole Prilosec 57 vasogenic edema 57 dietary antioxidants 57 hyperprolactinemia 57 impaired insulin secretion 57 dyslipidaemia 57 SE alleles 57 antiarrhythmic medications 57 CVD mortality 57 potentiation 57 calcium supplementation 57 pamidronate 57 prognostic indicators 57 P glycoprotein inhibitors 57 labetalol 57 prolactin levels 57 pioglitazone Actos 57 transferrin saturation 57 anticonvulsants 57 gene polymorphisms 57 CLA supplementation 57 immunoreactivity 57 serum lipid 57 lipoprotein metabolism 57 hypoglycemic episodes 57 Fulvestrant 57 tricyclic antidepressants TCAs 57 thrombophilia 57 mTOR inhibitors 57 neurohormonal 57 FGFs 57 platelet inhibitor 57 PECAM 1 57 COX2 57 apneic episodes 57 hypericin 57 Prilosec omeprazole 57 upregulates 57 sonographic appearance 57 elevated homocysteine 57 teriparatide 57 plasminogen activators 57 thienopyridine 57 postmenopausal hormone replacement 57 teratogens 57 antiinflammatory 57 immunological responses 57 antiestrogens 57 rFVIIa 57 Paxil paroxetine 57 COPD exacerbations 57 newer atypical antipsychotics 57 vasodilator 57 confounder 57 Drospirenone 57 severe hypersensitivity reactions 57 steroidogenic 57 Mechanistically 57 periodontal infection 57 Thiazolidinediones 57 androgen ablation 57 nasopharyngitis headache 57 atypical antipsychotic medications 57 prognostic marker 57 ACTOplus met XR 57 prognostically 57 Cognitive impairment 57 hepatic enzymes 57 lipid lowering medications 57 GFT# 57 leiomyomas 57 delayed gastric emptying 57 metabolic dysfunction 57 prucalopride 57 LDL cholesterol concentrations 57 teratogenic 57 serum PTH 57 chemopreventive 57 lichen planus 57 oral antidiabetic drugs 57 intravenous bisphosphonates 57 venous thromboembolic disease 57 muscarinic receptors 57 etiologic 57 lipid lowering drugs 57 fetal malformations 57 nonnucleoside reverse transcriptase inhibitors 57 sorafenib Nexavar 57 potassium sparing diuretics 57 troglitazone 57 prolonged QT interval 57 anticholinergics 57 piroxicam 57 lenalidomide dexamethasone 57 androgenic 57 homocysteine concentrations 57 tiagabine 57 adrenal hormone 57 TMP SMX 57 SGPT 57 coxibs 57 pioglitazone HCl 57 neuroprotective properties 57 glycemia 57 triglyceride concentrations 57 serum triglycerides 57 act synergistically 57 protein excretion 57 Combination therapy 57 redox active 57 dietary folate 57 teratogenic effects 57 indomethacin 57 hsCRP levels 57 PPAR agonist 57 atherogenic dyslipidemia 57 Oral corticosteroids 57 angiotensin converting enzyme inhibitors 57 diabetic kidney 57 surrogate markers 57 elevated creatinine 57 Genetic predisposition 57 sequela 57 thrombotic complications 57 nonhematologic adverse reactions 57 Vidaza azacitidine 57 AChE inhibitors 57 transaminase elevations 57 HER2 expression 57 thiazide diuretics 57 nicardipine 57 ACCORD Lipid 57 renal insufficiency 57 renoprotective 57 nonischemic 56 simvastatin ezetimibe 56 untreated hypothyroidism 56 cardiac fibrosis 56 tricyclic antidepressant 56 efalizumab 56 aldosterone antagonist 56 beta blocker therapy 56 Peripheral edema 56 lipid lowering agents 56 Telmisartan 56 HMG CoA reductase inhibitor 56 DHA supplementation 56 abdominal adiposity 56 neurotrophic 56 prothrombotic 56 PPAR gamma agonists 56 estrogen deficiency 56 aripiprazole Abilify 56 anticholinergic agents 56 antiarrhythmic drug 56 HepG2 cells 56 MYCAMINE 56 intensive lipid lowering 56 neuroregenerative 56 pulmonary toxicity 56 guggul 56 TCF#L# 56 multivitamin supplementation 56 airway hyperresponsiveness 56 Ivabradine 56 nonvertebral fracture 56 gemifloxacin 56 NSAID induced 56 somatostatin analogs 56 captopril 56 hypercalciuria 56 surrogate marker 56 macrovascular events 56 NAT2 56 rabeprazole 56 cerebral microbleeds 56 Febrile neutropenia 56 cranial irradiation 56 antiangiogenic therapy 56 overactive bladder symptoms 56 adrenergic agonists 56 trastuzumab Herceptin ® 56 Sgk1 56 liposomal amphotericin B 56 citalopram Celexa 56 lowering homocysteine 56 blood thinner Warfarin 56 intracerebral haemorrhage 56 phenytoin 56 5 HTTLPR 56 vildagliptin 56 IFN β 56 myocardial ischaemia 56 demonstrated antitumor activity 56 anti androgens 56 Chronic pancreatitis 56 thiazide diuretic 56 neutropenic patients 56 carotid atherosclerosis 56 CYP#A# inhibitors 56 antiangiogenic activity 56 Selective Serotonin Reuptake Inhibitor 56 autoimmune reactions 56 phosphodiesterase type 5 56 prostanoid 56 VEGF inhibitors 56 intracellular bacteria 56 bronchodilatory 56 dietary supplementation 56 genetic polymorphism 56 hematologic toxicity 56 immunosuppressive therapies 56 hyperplastic polyps 56 hormone therapy estrogen 56 serum phosphate levels 56 PHPT 56 insulin sensitizing agents 56 hepatic dysfunction 56 myocardial dysfunction 56 Interferon Beta 56 folate intake 56 Losartan 56 antiplatelet medication 56 neuroprotective agent 56 esomeprazole Nexium 56 diagnostic biomarker 56 beta adrenergic 56 CYP#C# gene 56 hemorrhagic complications 56 postprandial glycemia 56 silent myocardial ischemia 56 Randomized trials 56 coagulopathy 56 ZOLINZA 56 sonographic diagnosis 56 myocardial ischemia 56 HPA axis 56 leukocyte recruitment 56 pimozide 56 thromboprophylaxis 56 bezafibrate 56 Non Steroidal Anti Inflammatory 56 candesartan cilexetil 56 vivo coagulation 56 atypical femur fractures 56 SNP rs# [002] 56 ximelagatran 56 glucose homeostasis 56 Elevated serum 56 Contraindications 56 RBP4 56 antithrombotic 56 paclitaxel eluting stents 56 non selective NSAIDs 56 preterm neonates 56 fluoxetine Prozac 56 COREG 56 coinfected patients 56 opioid naïve 56 endothelial activation 56 inhibits platelet aggregation 56 TCF#L# gene 56 EXJADE 56 oral antidiabetes 56 IPAH 56 genotypic resistance 56 lipid elevations 56 impaired cognition 56 experimentally induced 56 Observational studies 56 serum concentrations 56 dyslipidemias 56 beta carotene supplements 56 N acetyl cysteine 56 Epidemiologic studies 56 EBV infection 56 pravastatin Pravachol 56 Brain derived neurotrophic 56 microvascular complications 56 Singh Manoux 56 serum calcium 56 Fondaparinux 56 etomidate 56 tegaserod 56 chlamydial 56 anti atherogenic 56 strontium ranelate 56 OPRM1 56 lamotrigine Lamictal 56 glitazone 56 coronary stenosis 56 symptomatic VTE 56 varespladib 56 antiestrogen 56 HIV HCV coinfected 56 lung epithelium 56 selective NSAIDs 56 metabolized differently 56 left ventricular dysfunction 56 salmeterol fluticasone 56 neuro protective 56 biphosphonates 56 Ziprasidone 56 lipid lowering therapy 56 bone scintigraphy 56 spontaneous preterm delivery 56 mechanistic insights 56 gastrointestinal GI bleeding 56 nondiabetic patients 56 PON1 56 Estriol 56 MERLIN TIMI 56 abnormal glucose metabolism 56 iron supplementation 56 celecoxib Celebrex 56 imipramine Tofranil 56 NATRECOR ® 56 idraparinux 56 hyperhomocysteinemia 56 colorectal adenomas 56 endogenous hormones 56 neuroleptic 56 anxiolytic 56 COX enzymes 56 parkinsonian symptoms 55 NUCYNTA TM 55 acetylcysteine 55 diabetic polyneuropathy 55 MAO inhibitors 55 noncardiac 55 STAT4 55 lenalidomide Revlimid 55 d4T stavudine Zerit 55 serum lipids 55 inhibit COX 55 neurocognitive deficits 55 Methotrexate MTX 55 Microalbuminuria 55 lumiracoxib 55 interferon alfa 2b 55 antihypertensive drugs 55 Plasma concentrations 55 cortical excitability 55 trans palmitoleate 55 folate supplementation 55 airway hyper responsiveness 55 systemic hypotension 55 Lp PLA 2 55 vitamin D inadequacy 55 edifoligide 55 TNF antagonist 55 Lantus insulin 55 WNK1 55 prognostic indicator 55 hypotensive 55 antiplatelet agent 55 APOE e4 55 headache nasopharyngitis 55 elevated CRP 55 bisoprolol 55 Vitamin B9 55 VADT 55 Valproate 55 immunosuppressive agents 55 apolipoprotein E4 55 tolvaptan 55 pharmacodynamic parameters 55 monogenic 55 poststroke depression 55 streptokinase 55 chronic thromboembolic pulmonary 55 BEXXAR Therapeutic Regimen 55 neuroactive 55 ERK signaling 55 lowers triglycerides 55 growth hormone secretion 55 Insulin detemir 55 ubiquinol 55 Insulin sensitivity 55 prednisone prednisolone 55 RISPERDAL ® 55 ziprasidone 55 dosing frequency 55 prognostic factor 55 hypothalamic pituitary 55 tumorigenicity 55 GP IIb IIIa inhibitors 55 syncope fainting 55 selegiline 55 premenstrual syndrome PMS 55 coronary microvascular 55 folic acid supplementation 55 Vasopressin 55 LRP5 55 Candida infection 55 upper gastrointestinal bleeding 55 azelaic acid 55 androgen deficiency 55 atherosclerotic vascular disease 55 cardiolipin 55 platelet reactivity 55 intravascular hemolysis 55 LT NS# 55 liver metastasis 55 Leydig cell 55 airway responsiveness 55 LV dysfunction 55 prolactin elevation 55 extrapyramidal symptoms EPS 55 anti leukemic 55 Heavy menstrual bleeding 55 ezetimibe simvastatin 55 APOC3 55 ACh 55 potentially hepatotoxic 55 coinfection 55 renal dysfunction 55 liver transaminases 55 Vitamin D supplementation 55 ergot alkaloids 55 tamoxifen Nolvadex ® 55 intracerebral 55 ddI 55 GnRH agonists 55 intact parathyroid hormone 55 chorioamnionitis 55 cinacalcet 55 antiemetics 55 adjuvant therapies 55 oligomerization 55 MGUS 55 Hcy 55 apolipoproteins 55 warfarin Coumadin 55 tolterodine 55 Akathisia 55 inhaled budesonide 55 serum estradiol 55 folate deficiency 55 DAPT 55 vitamin D supplementation 55 Cochrane reviewers 55 perioperative morbidity 55 corrected QT interval 55 Cytoxan 55 Tekturna ® 55 serotonin deficiency 55 serum creatinine levels 55 oral rivaroxaban 55 dysregulation 55 unmeasured factors 55 erlotinib Tarceva 55 Ranolazine 55 circulating IGF 55 NUCYNTA R 55 Orthostatic hypotension 55 reinfarction 55 reactogenicity 55 SAMe 55 inversely associated 55 tumor histology 55 Subclinical 55 phenothiazines 55 LOVENOX R 55 ovarian carcinoma 55 vasoactive 55 chromosomal rearrangement 55 mTOR inhibition 55 ventricular arrhythmia 55 esophageal squamous cell carcinoma 55 hypoperfusion 55 vitamin supplementation 55 IDH mutations 55 DLTs 55 Estrogen deficiency 55 antithrombotic therapy 55 ziprasidone Geodon 55 lowers LDL cholesterol 55 intestinal permeability 55 histologic subtypes 55 estrogen androgen 55 magnesium supplementation 55 hypothalamic pituitary adrenal axis 55 RBP4 levels 55 immunologic responses 55 mu opioid 55 H pylori 55 disulfiram 55 immune modulating 55 noscapine 55 postmenopausal hormone 55 dose dependently 55 BCL#A 55 SLC#A# [002] 55 lowering LDL cholesterol 55 hypercholesterolaemia 55 clinically meaningful differences 55 endothelial dysfunction 55 fasting glucose levels 55 impaired glucose metabolism 55 plasma homocysteine 55 phytoestrogen intake 55 LYSTEDA 55 GSTT1 55 remyelination 55 cAMP signaling 55 sertraline Zoloft 55 potassium excretion 55 antiviral efficacy 55 orthostatic hypotension 55 nephrotoxic 55 Soy isoflavones 55 aminotransferase 55 SSRI antidepressant 55 neuritic 55 Selective serotonin reuptake inhibitors 55 retrograde ejaculation 55 cTnT 55 plasma triglycerides 55 IV bisphosphonates 55 calcium homeostasis 55 LNG IUS 55 tryptase 55 CP CPPS 55 variant angina 55 chemopreventive agents 55 CYP#C# genotype 55 DMARDS 55 humanin 55 SSc 55 Known hypersensitivity 55 sedative hypnotics 55 cardiac insufficiency 55 intramuscular vaccination 55 neurologic symptoms 55 Hematologic toxicity 55 hsCRP 55 ALT elevations 55 Magnesium deficiency 55 autonomic dysfunction 55 subgroup analyzes 55 ramelteon 55 causal pathway 55 hydrobromide 55 GH deficiency 55 serum cortisol 55 lung cancer chemoprevention 55 sitosterol 55 APTIVUS r 55 activated microglia 55 cardiomegaly 55 excitotoxic 55 exendin 4 55 antihypertensive therapy 55 bile acid metabolism 55 circulating estrogens 55 Novartis Reclast 55 psychosocial variables 55 conventional antipsychotics 55 teratogenicity 55 genital tract infections 55 mecamylamine 55 gastro oesophageal reflux 55 skeletal muscle mass 55 heritable variation 55 raloxifene Evista 55 artery stenosis 55 selenium intake 55 neurodevelopmental outcomes 55 NIASPAN 55 jugular venous 54 MICARDIS 54 lumbar spine bone 54 tiotropium bromide 54 overactivation 54 GSTM1 gene 54 immunoregulatory 54 cerebral ischemia 54 Celebrex celecoxib 54 otamixaban 54 Apolipoprotein E 54 chlamydial infection 54 dobutamine 54 H. pylori eradication 54 insulin sensitizing drug 54 serum uric acid 54 clinically meaningful reductions 54 resistin 54 BYSTOLIC 54 postprandial hyperglycemia 54 selenium deficiency 54 tamsulosin 54 Bupropion 54 silibinin 54 pathophysiological 54 glomerular 54 SPARCL 54 anorexia cachexia 54 terazosin 54 pathogenic mechanisms 54 antihypertensive medication 54 hepatic enzyme 54 leukocyte counts 54 metabolic abnormality 54 microtubule targeting 54 paroxysmal AF 54 leukotriene receptor antagonist 54 lipid levels 54 inherited predisposition 54 intracranial bleeding 54 serum potassium 54 nonsteroidal 54 thyrotropin levels 54 T1DM 54 Aggrenox R 54 anti anginal 54 acetyl L carnitine 54 racemic mixture 54 ERK activation 54 Doxil ® 54 CHARISMA trial 54 autoregulation 54 cholesterol homeostasis 54 LHRH agonists 54 SOD2 54 intranasally administered 54 antithrombotics 54 inhibitory neurotransmitters 54 lowers homocysteine 54 endocrine dysfunction 54 RAS blockers 54 serum parathyroid hormone 54 hypoglycemic events 54 germline mutations 54 ergotamine 54 desipramine 54 repolarization 54 amyloid cascade 54 atorvastatin #mg 54 Stent thrombosis 54 bromocriptine 54 Pharmacodynamics 54 stratifying patients 54 osteoblast 54 angiotensin receptor blockers ARBs 54 prognostic markers 54 MTHFR gene 54 endogenous ligand 54 hyponatraemia 54 ibandronate 54 node metastases 54 eicosanoids 54 Montelukast 54 ziconotide 54 apolipoprotein B 54 urinary excretion 54 prognostic biomarker 54 TGFBR1 * 6A 54 antiepileptic drugs AEDs 54 thyroid dysfunction 54 ticlopidine 54 terbutaline 54 pretransplant 54 NMDA antagonists 54 tricyclic antidepressants 54 abnormal glucose tolerance 54 mutated K ras 54 antinuclear antibodies 54 Myfortic 54 antibody titer 54 hamartomas 54 #mg dose [001] 54 antiplatelet agents 54 magnesium intake 54 neurotoxicity 54 arterial stiffening 54 immuno modulatory 54 cystatin C 54 antimuscarinic 54 carotid bruit 54 nortriptyline Pamelor 54 Tylenol acetaminophen 54 sympathomimetic 54 paroxetine Paxil 54 carvedilol 54 nifedipine 54 JAK Inhibitor 54 subchronic 54 ranitidine Zantac 54 resynchronization therapy 54 Tranexamic acid 54 systemic inflammation 54 SOD2 gene 54 inhibit platelet function 54 pulmonary arterial 54 SOCS2 54 IKK2 54 prostate cancer PCa 54 hormone receptor negative 54 neutropenia dehydration dyspnea 54 cytogenetic abnormalities 54 Avanafil 54 coumadin 54 osteopenic 54 valsartan 54 intravenous cyclophosphamide 54 primidone